Longacre T A, Chung M H, Jensen D N, Hendrickson M R
Division of Surgical Pathology, Stanford University Medical Center, California 94305.
Am J Surg Pathol. 1995 Apr;19(4):371-406. doi: 10.1097/00000478-199504000-00001.
Existing criteria for separating clinically benign but architecturally complex or cytologically atypical endometrial proliferations (hyperplasia or metaplasia) from well-differentiated endometrial carcinoma are underspecified and poorly reproducible, in part due to the absence of a uniformly agreed on methodologically independent outcome against which to judge the efficacy of competing sets of criteria. Because myoinvasion is the first unambiguous indicator of clinically aggressive behavior for proliferations in this spectrum, we have employed the presence or absence of myoinvasion as a tool to develop clinically meaningful diagnostic criteria for the separation of complex atypical hyperplasia/metaplasia from well-differentiated carcinoma (CAHM/WDCA). We obtained the paired endometrial samplings and hysterectomy specimens of 520 patients; these were split into a training set of 306 cases and a test set of 214. The presence or absence of myoinvasion was assessed from an examination of the hysterectomy specimen. For the purposes of this study, myoinvasion was defined as the presence of irregular intramyometrial glands surrounded by a granulation tissue-like response. To determine the morphologic features that were most predictive of myoinvasion, a series of endometrial architectural, cytological, and stromal features was initially evaluated on the training set (149 myoinvasive and 157 nonmyoinvasive). Using a variety of exploratory data techniques including the classification algorithm CART, we developed a diagnostic rule for predicting myoinvasion that employed one architectural feature (glandular complexity captured by a pictorial architectural index) and two cytological features (nuclear pleomorphism and prominence of nucleoli). Extensive squamous differentiation, fibroblastic stroma, necrosis, stromal foam cells, and other cytologic features did not provide additional predictive value when cross-validated. The true misclassification rate of the CART-generated prediction rule was further assessed by applying the rule to the test set drawn largely from community hospitals. The sensitivity and specificity of this rule for detecting myoinvasion was 99.5 and 57%. The likelihood ratio was 2:1, (i.e., using prior odds of myoinvasion in the CAHM/WDCA spectrum of 1:10, the posterior odds on myoinvasion using the CART-generated rule would be 1:5). Comparison of the CART-generated myoinvasion prediction rule with the Kurman and Norris endometrial stromal invasion criteria for well differentiated endometrial carcinoma (25), using receiver operator characteristic curve (ROC) techniques, demonstrated a significant improvement in the ability to separate myoinvasive from non-myoinvasive endometrial proliferations with the CART-generated rule; the average area under the curve for the CART-generated rule was 0.78 (SE = 0.02) versus 0.67 (SE = 0.03) for the endometrial stromal invasion criteria.(ABSTRACT TRUNCATED AT 400 WORDS)
现有用于区分临床上为良性但结构复杂或细胞学上不典型的子宫内膜增殖(增生或化生)与高分化子宫内膜癌的标准不够明确且重现性差,部分原因是缺乏一种在方法学上独立且得到一致认可的结果,以此来判断相互竞争的标准集的有效性。由于肌层浸润是这一谱系中增殖性病变临床侵袭性行为的首个明确指标,我们将肌层浸润的有无作为一种工具,来制定具有临床意义的诊断标准,以区分复杂非典型增生/化生与高分化癌(CAHM/WDCA)。我们获取了520例患者的配对子宫内膜样本和子宫切除标本;将其分为一个包含306例病例的训练集和一个包含214例病例的测试集。通过检查子宫切除标本评估有无肌层浸润。在本研究中,肌层浸润定义为存在被肉芽组织样反应包绕的不规则肌层内腺体。为确定最能预测肌层浸润的形态学特征,最初在训练集(149例有肌层浸润和157例无肌层浸润)上评估了一系列子宫内膜结构、细胞学和间质特征。使用包括分类算法CART在内的多种探索性数据技术,我们制定了一个预测肌层浸润的诊断规则,该规则采用一个结构特征(由图像结构指数捕获的腺体复杂性)和两个细胞学特征(核多形性和核仁突出)。广泛的鳞状分化、成纤维细胞性间质、坏死、间质泡沫细胞及其他细胞学特征在交叉验证时未提供额外的预测价值。通过将该规则应用于主要来自社区医院的测试集,进一步评估了CART生成的预测规则的真实误分类率。该规则检测肌层浸润的敏感性和特异性分别为99.5%和57%。似然比为2:1,(即,在CAHM/WDCA谱系中肌层浸润的先验概率为1:10,使用CART生成的规则时肌层浸润的后验概率将为1:5)。使用受试者操作特征曲线(ROC)技术,将CART生成的肌层浸润预测规则与Kurman和Norris的高分化子宫内膜癌肌层浸润标准进行比较,结果表明CART生成的规则在区分有肌层浸润与无肌层浸润的子宫内膜增殖方面有显著改善;CART生成规则的曲线下平均面积为0.78(SE = 0.02),而子宫内膜间质浸润标准的曲线下平均面积为0.67(SE = 0.03)。(摘要截断于400字)